Literature DB >> 21195936

Metabolic syndrome and the genesis of uric acid stones.

Naim M Maalouf1.   

Abstract

Uric acid stones are significantly more common among nephrolithiasis patients with type 2 diabetes, obesity, and/or the metabolic syndrome. The principal metabolic feature responsible for this association is an overly acidic urine, which leads to the precipitation of sparingly soluble uric acid crystals in urine and subsequent development of stones. The unduly acidic urine in uric acid stone formers is caused by a combination of excessive dietary intake of animal proteins and a defect in renal ammoniagenesis and/or excretion that leads to impaired buffering and amplifies the acidic urine caused by an increased acid excretion.
Copyright © 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21195936      PMCID: PMC3053068          DOI: 10.1053/j.jrn.2010.10.015

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  17 in total

1.  Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism.

Authors:  Shalini T Reddy; Chia-Ying Wang; Khashayar Sakhaee; Linda Brinkley; Charles Y C Pak
Journal:  Am J Kidney Dis       Date:  2002-08       Impact factor: 8.860

2.  Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study.

Authors:  John C Lieske; Lourdes S Peña de la Vega; Matthew T Gettman; Jeffrey M Slezak; Eric J Bergstralh; L Joseph Melton; Cynthia L Leibson
Journal:  Am J Kidney Dis       Date:  2006-12       Impact factor: 8.860

3.  Biochemical profile of idiopathic uric acid nephrolithiasis.

Authors:  C Y Pak; K Sakhaee; R D Peterson; J R Poindexter; W H Frawley
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

4.  Type 2 diabetes increases the risk for uric acid stones.

Authors:  Michel Daudon; Olivier Traxer; Pierre Conort; Bernard Lacour; Paul Jungers
Journal:  J Am Soc Nephrol       Date:  2006-06-14       Impact factor: 10.121

5.  Pathophysiologic basis for normouricosuric uric acid nephrolithiasis.

Authors:  Khashayar Sakhaee; Beverley Adams-Huet; Orson W Moe; Charles Y C Pak
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

6.  The influence of a high dietary intake of purine-rich animal protein on urinary urate excretion and supersaturation in renal stone disease.

Authors:  B Fellström; B G Danielson; B Karlström; H Lithell; S Ljunghall; B Vessby
Journal:  Clin Sci (Lond)       Date:  1983-04       Impact factor: 6.124

7.  Low urine pH: a novel feature of the metabolic syndrome.

Authors:  Naim M Maalouf; Mary Ann Cameron; Orson W Moe; Beverley Adams-Huet; Khashayar Sakhaee
Journal:  Clin J Am Soc Nephrol       Date:  2007-08-16       Impact factor: 8.237

8.  Influence of body size on urinary stone composition in men and women.

Authors:  Michel Daudon; Bernard Lacour; Paul Jungers
Journal:  Urol Res       Date:  2006-02-11

9.  Comparative value of orange juice versus lemonade in reducing stone-forming risk.

Authors:  Clarita V Odvina
Journal:  Clin J Am Soc Nephrol       Date:  2006-08-30       Impact factor: 8.237

10.  Pharmacologic treatment of uric acid calculi.

Authors:  G M Preminger
Journal:  Urol Clin North Am       Date:  1987-05       Impact factor: 2.241

View more
  21 in total

1.  CUA Guideline: Management of ureteral calculi.

Authors:  Michael Ordon; Sero Andonian; Brian Blew; Trevor Schuler; Ben Chew; Kenneth T Pace
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

Review 2.  Epidemiology of stone disease across the world.

Authors:  Igor Sorokin; Charalampos Mamoulakis; Katsuhito Miyazawa; Allen Rodgers; Jamsheer Talati; Yair Lotan
Journal:  World J Urol       Date:  2017-02-17       Impact factor: 4.226

3.  Endoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formers.

Authors:  Boyd R Viers; John C Lieske; Terri J Vrtiska; Loren P Herrera Hernandez; Lisa E Vaughan; Ramilia A Mehta; Eric J Bergstralh; Andrew D Rule; David R Holmes; Amy E Krambeck
Journal:  Urology       Date:  2015-02-11       Impact factor: 2.649

Review 4.  Clinical consequences of Cushing's syndrome.

Authors:  Elena Valassi; Iris Crespo; Alicia Santos; Susan M Webb
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

5.  Approach to the Adult Kidney Stone Former.

Authors:  Naim Maalouf
Journal:  Clin Rev Bone Miner Metab       Date:  2012-03

Review 6.  Dietary recommendations and treatment of patients with recurrent idiopathic calcium stone disease.

Authors:  W G Robertson
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

Review 7.  Treatment of patients with uric acid stones.

Authors:  Ita Pfeferman Heilberg
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

8.  Kidney Stones as an Underrecognized Clinical Sign in Pediatric Cushing Disease.

Authors:  Sara H Rahman; Georgios Z Papadakis; Margaret F Keil; Fabio R Faucz; Maya B Lodish; Constantine A Stratakis
Journal:  J Pediatr       Date:  2015-12-15       Impact factor: 4.406

Review 9.  Metabolic evaluation of first-time and recurrent stone formers.

Authors:  David S Goldfarb; Omotayo Arowojolu
Journal:  Urol Clin North Am       Date:  2012-10-27       Impact factor: 2.241

Review 10.  Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence.

Authors:  Domenico Rendina; Gianpaolo De Filippo; Lanfranco D'Elia; Pasquale Strazzullo
Journal:  J Nephrol       Date:  2014-04-03       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.